{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:23:05Z","timestamp":1780471385809,"version":"3.54.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"DOI":"10.1097\/qai.0b013e31824aeaaa","type":"journal-article","created":{"date-parts":[[2012,4,22]],"date-time":"2012-04-22T04:43:16Z","timestamp":1335069796000},"page":"99-110","source":"Crossref","is-referenced-by-count":31,"title":["Permissive and Protective Factors Associated With Presence, Level, and Longitudinal Pattern of Cervicovaginal HIV Shedding"],"prefix":"10.1097","volume":"60","author":[{"given":"James","family":"Homans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Anastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Minkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardge","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaShonda Yvette","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Operskalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toinette","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-15-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":". Prevention of HIV-1 Infection with Early Antiretroviral Therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R3-15-20210131","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":". Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.","volume":"342","author":"Quinn","year":"2000","journal-title":"N Engl J Med"},{"key":"R4-15-20210131","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/317918","article-title":". Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.","volume":"183","author":"John","year":"2001","journal-title":"J Infect Dis"},{"key":"R5-15-20210131","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","article-title":". Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.","volume":"375","author":"Donnell","year":"2010","journal-title":"Lancet"},{"key":"R7-15-20210131","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(01)06653-3","article-title":". Determinants of HIV-1 shedding in the genital tract of women.","volume":"358","author":"Kovacs","year":"2001","journal-title":"Lancet"},{"key":"R8-15-20210131","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1097\/00002030-199712000-00001","article-title":". The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote dIvoire.","volume":"11","author":"Ghys","year":"1997","journal-title":"AIDS"},{"key":"R9-15-20210131","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/infdis\/170.6.1597","article-title":". Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA.","volume":"170","author":"Kreiss","year":"1994","journal-title":"J Infect Dis"},{"key":"R10-15-20210131","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QAD.0b013e32801424bd","article-title":". Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.","volume":"21","author":"Graham","year":"2007","journal-title":"AIDS"},{"key":"R11-15-20210131","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00002030-200310170-00004","article-title":". Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.","volume":"17","author":"Fiore","year":"2003","journal-title":"AIDS"},{"key":"R12-15-20210131","doi-asserted-by":"crossref","first-page":"12972","DOI":"10.1073\/pnas.2134064100","article-title":". HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.","volume":"100","author":"Kemal","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-15-20210131","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/0889222041217509","article-title":". Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female.","volume":"20","author":"Tirado","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R14-15-20210131","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/JVI.72.1.617-623.1998","article-title":". Human immunodeficiency virus type 1 populations in blood and semen.","volume":"72","author":"Delwart","year":"1998","journal-title":"J Virol"},{"issue":"suppl 1","key":"R15-15-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/753312748","article-title":"Human immunodeficiency virus type 1 compartmentalization in the central nervous system.","volume":"10","author":"Petito","year":"2004","journal-title":"J Neurovirol"},{"key":"R16-15-20210131","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1128\/JVI.78.18.10133-10148.2004","article-title":". Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.","volume":"78","author":"Smit","year":"2004","journal-title":"J Virol"},{"key":"R17-15-20210131","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/321000","article-title":". Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions.","volume":"184","author":"Ellerbrock","year":"2001","journal-title":"J Infect Dis"},{"key":"R18-15-20210131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mob.2001.108999","article-title":". Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration.","volume":"184","author":"Wright","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R19-15-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/426394","article-title":". Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.","volume":"191","author":"Sha","year":"2005","journal-title":"J Infect Dis"},{"key":"R20-15-20210131","doi-asserted-by":"crossref","first-page":"e17480","DOI":"10.1371\/journal.pone.0017480","article-title":". Correlates of HIV-1 genital shedding in Tanzanian women.","volume":"6","author":"Tanton","year":"2011","journal-title":"PLoS ONE"},{"key":"R21-15-20210131","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ajog.2004.10.609","article-title":". The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.","volume":"192","author":"Spinillo","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R22-15-20210131","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/QAD.0b013e32825a69bd","article-title":". Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.","volume":"21","author":"Legoff","year":"2007","journal-title":"AIDS"},{"key":"R23-15-20210131","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/00002030-200108170-00011","article-title":". A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding.","volume":"15","author":"Al-Harthi","year":"2001","journal-title":"AIDS"},{"key":"R24-15-20210131","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/00002030-200009290-00005","article-title":". Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.","volume":"14","author":"Reichelderfer","year":"2000","journal-title":"AIDS"},{"key":"R25-15-20210131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":". Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R26-15-20210131","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002030-200003100-00015","article-title":". Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.","volume":"14","author":"Cu-Uvin","year":"2000","journal-title":"AIDS"},{"key":"R27-15-20210131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.qai.0000248352.18007.1f","article-title":". Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.","volume":"44","author":"Neely","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-15-20210131","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/QAD.0b013e32833e5043","article-title":". Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.","volume":"24","author":"Cu-Uvin","year":"2010","journal-title":"AIDS"},{"key":"R29-15-20210131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/527387","article-title":". Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.","volume":"46","author":"Kwara","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R30-15-20210131","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/323660","article-title":". Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.","volume":"184","author":"Coombs","year":"2001","journal-title":"J Infect Dis"},{"key":"R31-15-20210131","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1086\/338447","article-title":". The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions.","volume":"185","author":"Villanueva","year":"2002","journal-title":"J Infect Dis"},{"key":"R32-15-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":". The Womens Interagency HIV Study. WIHS Collaborative Study Group.","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"R33-15-20210131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1086\/376509","article-title":". Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.","volume":"188","author":"Landay","year":"2003","journal-title":"J Infect Dis"},{"key":"R34-15-20210131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcv.2007.08.021","article-title":". Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.","volume":"41","author":"Operskalski","year":"2008","journal-title":"J Clin Virol"},{"key":"R35-15-20210131","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"R36-15-20210131","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","article-title":". Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.","volume":"91","author":"Palefsky","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R37-15-20210131","first-page":"139","article-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. AIDSInfo.","volume":"1-","year":"2011","journal-title":"March"},{"key":"R38-15-20210131","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.qai.0000229997.52246.95","article-title":". Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months.","volume":"42","author":"Cu-Uvin","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R39-15-20210131","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1086\/315514","article-title":". Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.","volume":"181","author":"Lawn","year":"2000","journal-title":"J Infect Dis"},{"key":"R40-15-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/OLQ.0b013e318186decf","article-title":". Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.","volume":"36","author":"Kissinger","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R41-15-20210131","doi-asserted-by":"crossref","first-page":"454","DOI":"10.15288\/jsad.2008.69.454","article-title":". Alcohol consumption and HIV-1 vaginal RNA shedding among women.","volume":"69","author":"Theall","year":"2008","journal-title":"J Stud Alcohol Drugs"},{"key":"R42-15-20210131","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/aid.2006.22.589","article-title":". Chronic alcohol consumption results in higher simian immunodeficiency virus replication in mucosally inoculated rhesus macaques.","volume":"22","author":"Poonia","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R43-15-20210131","first-page":"351","article-title":". Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV-1 and on CD4 and CD8 lymphocytes.","volume":"325","author":"Bagasra","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"R44-15-20210131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/589621","article-title":". Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.","volume":"198","author":"Nagot","year":"2008","journal-title":"J Infect Dis"},{"key":"R45-15-20210131","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4414\/bms.2008.13252","article-title":". Les personnes seropositives ne souffrant daucune autre MST et suivant un traitement antiretroviral efficace ne transmettent pas le VIH par voie sexuelle.","volume":"89","author":"Vernazza","year":"2008","journal-title":"Bulletin des Medecins Suisses"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e31824aeaaa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:54:59Z","timestamp":1620971699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201205010-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31824aeaaa","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,1]]}}}